Table 2 Univariate and multivariate Cox regression of TAGLN2 expression for overall survival in glioma patients
From: TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas
Variable | Univariate Cox Regression | Multivariate Cox Regression | ||
|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Age Increasing years | 1.038 (1.023–1.054) | <0.001 | 0.993 (0.975–1.011) | 0.446 |
Gender Female vs male | 0.847 (0.600–1.195) | 0.345 | ||
WHO grade High- vs low- | 5.840 (4.015–8.494) | <0.001 | 3.128 (1.969–4.971) | <0.001 |
TAGLN2 expression High vs low | 2.121 (1.843–2.442) | <0.001 | 1.713 (1.384–2.119) | <0.001 |
IDH1 status Mutation vs wild-type | 0.256 (0.178–0.368) | <0.001 | 0.869 (0.501–1.510) | 0.619 |
Radiotherapy Yes vs no | 0.429 (0.296–0.622) | <0.001 | 0.439 (0.303–0.638) | <0.001 |